Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
EBITDA Over Time
Profitability under pressure
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-8.12M
↑ 13% above average
Average (9y)
$-9.37M
Historical baseline
Range
High:$-6.13M
Low:$-14.13M
CAGR
+2.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-8.12M | +0.7% |
| 2023 | $-8.18M | +18.9% |
| 2022 | $-10.08M | +21.4% |
| 2021 | $-12.83M | +9.2% |
| 2020 | $-14.13M | -17.8% |
| 2019 | $-11.99M | -95.8% |
| 2018 | $-6.13M | +14.5% |
| 2017 | $-7.17M | +17.4% |
| 2016 | $-8.68M | -35.6% |
| 2015 | $-6.40M | - |